Nov 17, 2021 / NTS GMT
Vamsi Krishna - SMS Pharmaceuticals Ltd. - Executive Director
By our financial highlights. So SMS Pharma was established in 1990. SMS pharma is a global API intermediate player with strong research and manufacturing teams supported by state of the art manufacturing facilities. It has capabilities for a wide range of APIs intermediates and has handled varied process reactions and reactor volumes up to 3,000 KL.
Undertaking contract manufacturing of API and advanced and basic intermediates offering a competitive advantage to the clients, especially in the latest stage life cycle of the products. With a demonstrated manufacturing excellence over last two decades in broad portfolio of therapeutic segment, the company has become a trusted partner to a customer base in over 70 countries, including clientele in top 20 pharmaceutical companies.
The API segment is focused on providing products across a diverse range of therapies such as ARVs, antivirals, antiulcer, antimigraine, antiepileptic, anti-erectile dysfunction. This strategy is to focus on equality market leadership and backward integration,
Q2 2022 SMS Pharmaceuticals Ltd Earnings Call Transcript
Nov 17, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers